Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Complex medical history of a patient with a compound heterozygous mutation in C1QC.

Lubbers R, Beaart-van de Voorde LJJ, van Leeuwen K, de Boer M, Gelderman KA, van den Berg MJ, Ketel AG, Simon A, de Ree J, Huizinga TWJ, Steup-Beekman GM, Trouw LA.

Lupus. 2019 Sep;28(10):1255-1260. doi: 10.1177/0961203319865029. Epub 2019 Jul 29.

2.

Complement Component C1q as Serum Biomarker to Detect Active Tuberculosis.

Lubbers R, Sutherland JS, Goletti D, de Paus RA, van Moorsel CHM, Veltkamp M, Vestjens SMT, Bos WJW, Petrone L, Del Nonno F, Bajema IM, Dijkman K, Verreck FAW, Walzl G, Gelderman KA, Groeneveld GH, Geluk A, Ottenhoff THM, Joosten SA, Trouw LA.

Front Immunol. 2018 Oct 23;9:2427. doi: 10.3389/fimmu.2018.02427. eCollection 2018.

3.

Reference Intervals of Factor H and Factor H-Related Proteins in Healthy Children.

van Beek AE, Kamp A, Kruithof S, Nieuwenhuys EJ, Wouters D, Jongerius I, Rispens T, Kuijpers TW, Gelderman KA.

Front Immunol. 2018 Aug 2;9:1727. doi: 10.3389/fimmu.2018.01727. eCollection 2018.

4.

Analytical validation of the Hevylite assays for M-protein quantification.

Jacobs JFM, Haagen IA, Lodder A, van der Kroft C, de Kat Angelino CM, Croockewit S, Nieuwenhuys E, Gelderman KA.

Clin Chem Lab Med. 2018 Jun 27;56(7):1169-1175. doi: 10.1515/cclm-2017-0817.

PMID:
29397379
5.

Corrigendum: Exome Sequencing Reveals Primary Immunodeficiencies in Children with Community-Acquired Pseudomonas aeruginosa Sepsis.

Asgari S, McLaren PJ, Peake J, Wong M, Wong R, Bartha I, Francis JR, Abarca K, Gelderman KA, Agyeman P, Aebi C, Berger C, Fellay J, Schlapbach LJ; Swiss Pediatric Sepsis Study.

Front Immunol. 2016 Oct 27;7:447. eCollection 2016.

6.

Exome Sequencing Reveals Primary Immunodeficiencies in Children with Community-Acquired Pseudomonas aeruginosa Sepsis.

Asgari S, McLaren PJ, Peake J, Wong M, Wong R, Bartha I, Francis JR, Abarca K, Gelderman KA, Agyeman P, Aebi C, Berger C, Fellay J, Schlapbach LJ; Swiss Pediatric Sepsis Study.

Front Immunol. 2016 Sep 20;7:357. eCollection 2016. Erratum in: Front Immunol. 2016 Oct 27;7:447.

7.

Advanced glycation end products (AGEs) and the soluble receptor for AGE (sRAGE) in patients with type 1 diabetes and coeliac disease.

Bakker SF, Tushuizen ME, Gözütok E, Çiftci A, Gelderman KA, Mulder CJ, Simsek S.

Nutr Metab Cardiovasc Dis. 2015 Feb;25(2):230-5. doi: 10.1016/j.numecd.2014.10.009. Epub 2014 Nov 1.

PMID:
25467215
8.

Increased IgA glycoprotein-2 specific antibody titres in refractory celiac disease.

Gross S, Bakker SF, van Bodegraven AA, van Hoogstraten IM, Gelderman KA, Bouma G, Mulder CJ, von Blomberg BM, Bontkes HJ.

J Gastrointestin Liver Dis. 2014 Jun;23(2):127-33.

9.

Serum autoantibodies directed against transglutaminase-2 have a low avidity compared with alloantibodies against gliadin in coeliac disease.

Gelderman KA, Drop AC, Trouw LA, Bontkes HJ, Bouma G, van Hoogstraten IM, von Blomberg BM.

Clin Exp Immunol. 2014 Jul;177(1):86-93. doi: 10.1111/cei.12302.

10.

The NOX2-mediated ROS producing capacity of recipient cells is associated with reduced T cell infiltrate in an experimental model of chronic renal allograft inflammation.

Kraaij MD, Koekkoek KM, Gelderman KA, van Kooten C.

Transpl Immunol. 2014 Mar;30(2-3):65-70. doi: 10.1016/j.trim.2013.12.001. Epub 2013 Dec 21.

PMID:
24365514
11.

Subsets of human type 2 macrophages show differential capacity to produce reactive oxygen species.

Kraaij MD, Koekkoek KM, van der Kooij SW, Gelderman KA, van Kooten C.

Cell Immunol. 2013 Jul-Aug;284(1-2):1-8. doi: 10.1016/j.cellimm.2013.07.006. Epub 2013 Jul 18.

PMID:
23916683
12.

Differential IL-13 production by small intestinal leukocytes in active coeliac disease versus refractory coeliac disease.

Gross S, van Wanrooij RL, Nijeboer P, Gelderman KA, Cillessen SA, Meijer GA, Mulder CJ, Bouma G, von Blomberg BM, Bontkes HJ.

Mediators Inflamm. 2013;2013:939047. doi: 10.1155/2013/939047. Epub 2013 Apr 15.

13.

Antibody titers against food antigens decrease upon a gluten-free diet, but are not useful for the follow-up of (refractory) celiac disease.

Gross S, van Wanrooij RL, Tack GJ, Gelderman KA, Bakker SF, van Hoogstraten IM, Neefjes-Borst EA, Schreurs MW, Bouma G, Mulder CJ, von Blomberg BM, Bontkes HJ.

Eur J Gastroenterol Hepatol. 2013 Apr;25(4):516-8. doi: 10.1097/MEG.0b013e32835dca77. No abstract available.

PMID:
23337171
14.

Dexamethasone increases ROS production and T cell suppressive capacity by anti-inflammatory macrophages.

Kraaij MD, van der Kooij SW, Reinders ME, Koekkoek K, Rabelink TJ, van Kooten C, Gelderman KA.

Mol Immunol. 2011 Dec;49(3):549-57. doi: 10.1016/j.molimm.2011.10.002. Epub 2011 Nov 1.

PMID:
22047959
15.

Dendritic cells as a tool to induce transplantation tolerance: obstacles and opportunities.

van Kooten C, Lombardi G, Gelderman KA, Sagoo P, Buckland M, Lechler R, Cuturi MC.

Transplantation. 2011 Jan 15;91(1):2-7. Review.

PMID:
21452405
16.

CD68-expressing cells can prime T cells and initiate autoimmune arthritis in the absence of reactive oxygen species.

Pizzolla A, Gelderman KA, Hultqvist M, Vestberg M, Gustafsson K, Mattsson R, Holmdahl R.

Eur J Immunol. 2011 Feb;41(2):403-12. doi: 10.1002/eji.201040598. Epub 2010 Dec 23.

17.

In vitro-generated DC with tolerogenic functions: perspectives for in vivo cellular therapy.

van Kooten C, Gelderman KA.

Methods Mol Biol. 2011;677:149-59. doi: 10.1007/978-1-60761-869-0_10.

PMID:
20941608
18.

Induction of regulatory T cells by macrophages is dependent on production of reactive oxygen species.

Kraaij MD, Savage ND, van der Kooij SW, Koekkoek K, Wang J, van den Berg JM, Ottenhoff TH, Kuijpers TW, Holmdahl R, van Kooten C, Gelderman KA.

Proc Natl Acad Sci U S A. 2010 Oct 12;107(41):17686-91. doi: 10.1073/pnas.1012016107. Epub 2010 Sep 22.

19.

Ncf1-associated reduced oxidative burst promotes IL-33R+ T cell-mediated adjuvant-free arthritis in mice.

Hagenow K, Gelderman KA, Hultqvist M, Merky P, Bäcklund J, Frey O, Kamradt T, Holmdahl R.

J Immunol. 2009 Jul 15;183(2):874-81. doi: 10.4049/jimmunol.0900966. Epub 2009 Jun 24.

20.

The protective role of ROS in autoimmune disease.

Hultqvist M, Olsson LM, Gelderman KA, Holmdahl R.

Trends Immunol. 2009 May;30(5):201-8. doi: 10.1016/j.it.2009.03.004. Epub 2009 Apr 6. Review.

PMID:
19356981
21.

Handbook of experimental pharmacology "dendritic cells": the use of dexamethasone in the induction of tolerogenic DCs.

van Kooten C, Stax AS, Woltman AM, Gelderman KA.

Handb Exp Pharmacol. 2009;(188):233-49. doi: 10.1007/978-3-540-71029-5_11. Review.

PMID:
19031029
22.

Induction of donor-specific T-cell hyporesponsiveness using dexamethasone-treated dendritic cells in two fully mismatched rat kidney transplantation models.

Stax AM, Gelderman KA, Schlagwein N, Essers MC, Kamerling SW, Woltman AM, van Kooten C.

Transplantation. 2008 Nov 15;86(9):1275-82. doi: 10.1097/TP.0b013e31818a6682.

PMID:
19005410
23.

Complement production and regulation by dendritic cells: molecular switches between tolerance and immunity.

van Kooten C, Fiore N, Trouw LA, Csomor E, Xu W, Castellano G, Daha MR, Gelderman KA.

Mol Immunol. 2008 Oct;45(16):4064-72. doi: 10.1016/j.molimm.2008.07.015. Review.

PMID:
18926283
24.

Generation and characterization of a novel anti-rat CD40L antibody with inhibitory activities in vitro and in vivo.

Stax AM, Gelderman KA, Kamerling SW, van der Geest R, Schlagwein N, van Kooten C.

J Immunol Methods. 2008 Jun 1;335(1-2):46-52. doi: 10.1016/j.jim.2008.02.013. Epub 2008 Mar 20.

PMID:
18384807
25.

Macrophages suppress T cell responses and arthritis development in mice by producing reactive oxygen species.

Gelderman KA, Hultqvist M, Pizzolla A, Zhao M, Nandakumar KS, Mattsson R, Holmdahl R.

J Clin Invest. 2007 Oct;117(10):3020-8.

26.

C4b-binding protein and factor H compensate for the loss of membrane-bound complement inhibitors to protect apoptotic cells against excessive complement attack.

Trouw LA, Bengtsson AA, Gelderman KA, Dahlbäck B, Sturfelt G, Blom AM.

J Biol Chem. 2007 Sep 28;282(39):28540-8. Epub 2007 Aug 15.

27.

Rheumatoid arthritis: the role of reactive oxygen species in disease development and therapeutic strategies.

Gelderman KA, Hultqvist M, Olsson LM, Bauer K, Pizzolla A, Olofsson P, Holmdahl R.

Antioxid Redox Signal. 2007 Oct;9(10):1541-67. Review.

PMID:
17678439
28.

Lack of reactive oxygen species breaks T cell tolerance to collagen type II and allows development of arthritis in mice.

Hultqvist M, Bäcklund J, Bauer K, Gelderman KA, Holmdahl R.

J Immunol. 2007 Aug 1;179(3):1431-7.

29.

A new arthritis therapy with oxidative burst inducers.

Hultqvist M, Olofsson P, Gelderman KA, Holmberg J, Holmdahl R.

PLoS Med. 2006 Sep;3(9):e348.

30.

T cell surface redox levels determine T cell reactivity and arthritis susceptibility.

Gelderman KA, Hultqvist M, Holmberg J, Olofsson P, Holmdahl R.

Proc Natl Acad Sci U S A. 2006 Aug 22;103(34):12831-6. Epub 2006 Aug 14.

31.
32.

Inhibiting complement regulators in cancer immunotherapy with bispecific mAbs.

Gelderman KA, Lam S, Gorter A.

Expert Opin Biol Ther. 2005 Dec;5(12):1593-601. Review.

PMID:
16318423
34.

Complement function in mAb-mediated cancer immunotherapy.

Gelderman KA, Tomlinson S, Ross GD, Gorter A.

Trends Immunol. 2004 Mar;25(3):158-64. Review. No abstract available.

PMID:
15036044
35.
36.

CD55 expression patterns on intestinal neuronal tissue are divergent from the brain.

Gelderman KA, Zijlmans HJ, Vonk MJ, Gorter A.

Gut. 2004 Apr;53(4):507-13.

37.

Membrane-bound complement regulatory proteins inhibit complement activation by an immunotherapeutic mAb in a syngeneic rat colorectal cancer model.

Gelderman KA, Hakulinen J, Hagenaars M, Kuppen PJ, Meri S, Gorter A.

Mol Immunol. 2003 Sep;40(1):13-23.

PMID:
12909127
38.

Cytokines affect resistance of human renal tumour cells to complement-mediated injury.

Blok VT, Gelderman KA, Tijsma OH, Daha MR, Gorter A.

Scand J Immunol. 2003 Jun;57(6):591-9.

40.

Supplemental Content

Loading ...
Support Center